Show Summary Details
Page of

Implantable Cardioverter-Defibrillator Trials and Prevention of Sudden Cardiac Death 

Implantable Cardioverter-Defibrillator Trials and Prevention of Sudden Cardiac Death
Chapter:
Implantable Cardioverter-Defibrillator Trials and Prevention of Sudden Cardiac Death
Author(s):

Bernard J. Gersh

DOI:
10.1093/med/9780199915712.003.0694
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 December 2018

Since the early 1980s, the development of implantable cardioverter-defibrillators (ICDs) has revolutionized the approach to prevention of sudden cardiac death. Multiple clinical trials have defined the indications for ICD therapy in the prevention of primary and secondary sudden cardiac death. The current understanding of risk stratification is a victory for evidence-based medicine; perhaps no other area of cardiology has been so rigorously evaluated. As such, these fact-driven clinical trials are rich fodder for the cardiology board examination.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.